Sacroiliitis Market Share

Sacroiliitis Market Scenario

The Sacroiliitis Market is projected to reach USD 0.65 Billion by 2030 at 19.10% CAGR during the forecast period 2022-2030. Sacroiliitis is a medical condition where there is inflammation in one or both sacroiliac joints situated in the pelvis and lower back. The function of a sacroiliac joint is to bear the weight of the upper body while standing, walking, and others. The condition can be diagnosed by imaging techniques. Sacroiliitis is caused due to traumatic injury, arthritis, pregnancy, infection, spondylitis, and others. The increasing prevalence of arthritis is the key factor for the market growth. According to the Centers for Disease Control and Prevention (2013to 2015), 22.7% Americans of the total population had arthritis, annually. Thus, such a high prevalence of arthritis and increasing government funding for the healthcare sector enhance the growth of this market.

However, factors such as expensive diagnostic tests and the high cost of surgical procedures are expected to restrict the market growth during the forecast period.

Segmentation

The sacroiliitis market is segmented on the basis of diagnosis, treatment, and end-user. The sacroiliitis industry, by diagnosis, is sub-segmented into imaging tests and anesthetic injections. The imaging tests category includes x-ray, MRI, and CT scan. On the basis of treatment, the market is categorized into medications, joint injections, radiofrequency denervation, electrical stimulation, joint fusion, facet block, chiropractic manipulation, and physical therapy. On the basis of end-user, the market is segmented into hospitals and clinics, pharmacies, and diagnostic centers.

On the basis of region, the sacroiliitis market is segmented into the Americas, Europe, Asia-Pacific, and the Middle East and Africa.

The Americas is sub-segmented into North America and South America. The North American region is further segmented into the US and Canada. The European region is divided into two, namely, Western Europe and Eastern Europe. Western Europe is further classified into Germany, Italy, France, the UK, Spain, and the rest of Western Europe. The Asia-Pacific region is sub-segmented into Japan, China, India, Australia, the Republic of Korea, and the rest of Asia-Pacific. The Middle Eastern and African region is sub-segmented into the United Arab Emirates, Saudi Arabia, Oman, Kuwait, Qatar, and the rest of the Middle East and Africa.

Key players

Some of the key players in the sacroiliitis market are Medacta International, SI-BONE, Globus Medical, Zyga Technology, Nutech Medical, CoorsTek Medical LLC, Aspen Medical Products, Medtronic, and others.

Regional Market Summary

Sacroiliitis Market Share (%), by Region, 2017

Sources: Centers for Disease Control and Prevention

The sacroiliitis market is dominated by North America owing to the high prevalence of arthritis and high healthcare investments within this region. According to the Centers for Disease Control and Prevention by 2040, 78.4 million will have doctor-diagnosed arthritis.

The rising adoption of technologically advanced systems for early diagnosis of diseases also drives the market growth in this region.

It is estimated that Europe stood second in the sacroiliitis market. The increasing prevalence of lower back disorders and the availability of minimally invasive surgical procedures for sacroiliitis drive the market growth in this region. According to The European (2015), sacroiliac joint was the main reason for chronic low back pain in Europe.

Asia-Pacific was projected to be the fastest growing region for the sacroiliitis market. Key factors such as the growing patient pool, the high prevalence of chronic diseases, developing healthcare infrastructure, and increasing research and development activities in the biotechnology sector influence the market in this region. The presence of major market players such as China, India, and Japan drives the market growth.

The Middle East and Africa holds the least share of the sacroiliitis market due to the presence of stringent government policies and poor economies. However, growing awareness among the population, rising government initiatives to improve the healthcare sector, and high investments by private market players in this region can boost the market growth. 

Intended Audience

• Pharmaceutical companies


• Biotechnological institutes


• Government and private laboratories


• Research and Development (R&D) companies


• Medical research laboratories


• Market research and consulting service providers

Market Segmentation and Key Market Players

Sacroiliitis Market, by Diagnosis,

• Imaging tests




• X-ray


• MRI


• CT scan




• Anesthetic injections

Sacroiliitis Market, by Treatment

• Medications




• Pain relievers


• Muscle relaxants


• TNF inhibitors




• Joint injections


• Radiofrequency denervation


• Electrical stimulation


• Joint fusion


• Facet block


• Chiropractic manipulation


• Physical therapy

Sacroiliitis Market, by End-User

• Hospitals & Clinics


• Pharmacies


• Diagnostic Centers

Sacroiliitis Market, by Region

• Americas


• Europe


• Asia-Pacific


• Middle East & Africa

Sacroiliitis Market, by Key Players

• Medacta International


• SI-BONE


• Globus Medical


• Zyga Technology


• Nutech Medical


• CoorsTek Medical LLC


• Aspen Medical Products


• Medtronic


• Others